Literature DB >> 25457071

Postural control in Parkinson's disease.

Jackeline Yumi Fukunaga1, Rafaela Maia Quitschal2, Flávia Doná3, Henrique Ballalai Ferraz4, Maurício Malavasi Ganança5, Heloísa Helena Caovilla6.   

Abstract

INTRODUCTION: Postural instability is one of the most disabling features of Parkinson's disease.
OBJECTIVE: To evaluate postural balance in Parkinson's disease.
METHODS: Thirty patients with Parkinson's disease were compared with controls using Tetrax™ interactive balance system posturography.
RESULTS: For different positions, patients with Parkinson's disease showed a significantly higher weight distribution index, fall index, Fourier transformation at low-medium frequencies (F2-F4), and significantly lower right/left and toe/heel synchronization versus controls.
CONCLUSION: Postural imbalance in Parkinson's disease patients is characterized by the abnormalities of weight distribution index, synchronization index, Fourier transformation index, and fall index as measured by Tetrax™ posturography.
Copyright © 2014 Associação Brasileira de Otorrinolaringologia e Cirurgia Cérvico-Facial. Published by Elsevier Editora Ltda. All rights reserved.

Entities:  

Keywords:  Doença de Parkinson; Equilíbrio postural; Parkinson disease; Postural balance; Testes de função vestibular; Vestibular function tests

Mesh:

Year:  2014        PMID: 25457071      PMCID: PMC9442668          DOI: 10.1016/j.bjorl.2014.05.032

Source DB:  PubMed          Journal:  Braz J Otorhinolaryngol        ISSN: 1808-8686


Introduction

Postural balance can be defined as the ability of human beings to stand up straight and perform movements with no oscillations or falls. Its maintenance is determined by the integration in the central nervous system of information originating from the vestibular, visual, and proprioceptive systems that trigger eye and spinal reflexes.1, 2, 3, 4 The vestibular-ocular reflex (VOR) generates eye movements, promoting the stabilization of gaze during head movement; the vestibulospinal reflex (VSR) generates compensatory body movements in order to maintain head and postural stability. Parkinson's disease is a chronic and progressive degenerative disorder of the central nervous system. It affects all age groups, but is most commonly found in the elderly population. Parkinson's disease can be considered the second most common senile neurodegenerative disease, affecting approximately 1% to 2% of the population above 65 years of age, and occurs in different races and social classes in both genders, but is prevalent in males. Parkinson's disease is characterized by rigidity, bradykinesia, micrography, mask-like facial expression, postural changes, and resting tremor. Postural changes include lack of balance reaction, adopting the posture in flexion, and decreased trunk rotation. It is considered that the fall risk in Parkinson's disease varies between 38% and 68%, and that recurrent falls occur more often in the later stages of the disease. The pathophysiology of Parkinson's disease is a progressive loss of cells in the substantia nigra of the midbrain. The degeneration of neurons in the substantia nigra results in decreased production of dopamine, with depigmentation of this structure.7, 8 The etiology remains unknown, and it is believed that the pathogenic mechanisms involved are multifactorial: oxidative stress, mitochondrial abnormalities, excitotoxicity, glial and inflammatory factors, environmental neurotoxins, genetic factors, and brain aging.10, 11 Patients with Parkinson's disease exhibit more difficulty in executing simultaneous movements and sequencial tasks versus simple tasks, requiring the complete execution of one movement before starting the next. Postural instability is a major problem in Parkinson's disease; it increases the frequency of fall episodes and their consequences, and the likelihood of occurrence of falls increases according to the extent and duration of the disease.8, 12 Progression of the disease leads to an impairment of gait called festination, characterized by decreased speed and shortening of the stride, as if the person were chasing his own center of gravity, with a tendency to tip over forward. Festinant gait may be caused by a change of pressure and mass centers, resulting in a reduction of the responses of balance, or as a result of changes in gait kinematics. Changes in gait kinematics include changes in joint excursion and in hip flexion, which can modify the excursion of the heel. Instead of a heel-toe progression, the patient makes contact with the ground with flat feet; or, with the advance of the disease, there is a heel-toe progression, significantly compromising the gait.8, 13 Posturography measures postural instability, assists in the analysis of the functional aspects of whatever dysfunction causes the body imbalance,8, 14, 15 complements conventional vestibular tests for diagnosis, and is relevant to the staging, treatment, and prognosis of Parkinson's disease.16, 17 It may also identify early signs of balance impairment in different conditions, such as with eyes open, eyes closed, and on unstable surfaces.8, 18 Research has demonstrated that healthy individuals have better postural control and a higher stability limit than patients with Parkinson's disease in the on period, a phase where the patient is under the influence of anti-Parkinsonian medication and presents better motor performance, and in the off period, where there is no effect of medication and consequently a worsening of symptoms; Parkinson patients perform better in the on period than in the off period.19, 20 Most posturographic devices in current use assume that the mechanisms involved in postural control can be measured by analyzing the postural oscillation manifested by a shifting of the center of gravity or pressure, while the subject remains standing on a platform sensitive to pressure. In Tetrax™ (Sunlight Medical Ltd.) interactive balance system posturography, created by Kohen-Raz with four platforms, postural control is investigated through the difference in pressure on each platform. This equipment makes it possible to obtain and separately compare the values of forefoot and rearfoot (toes and heel) of each foot, and of each heel with the contralateral forefoot. The body balance of healthy individuals was analyzed with Tetrax™ in different sensory conditions (eyes open or eyes closed and with head turned 45° to the right or to the left, or with a tilt of 30° forward or backward, on a firm or unstable surface), with reference to the general stability index, weight distribution index, synchronization to the right/left, synchronization of toes/heel, and fall risk. This research was motivated by the authors’ finding that only two studies used Tetrax™ in patients with Parkinson's disease,23, 24 and by the need to more broadly assess the postural control of patients with this disease.

Objective

This study aimed to assess the postural control in patients with Parkinson's disease.

Methods

This clinical, cross-sectional study with a consecutive sample was initiated after a review and approval by the ethics committee on research with human subjects under No. 1415-11. All volunteers were evaluated between 2011 and 2012 and were informed of the procedures that would be performed; in addition, these volunteers signed an informed consent allowing their participation in the study and subsequent publication of the results. Thirty male and female patients with neurological diagnosis of idiopathic Parkinson's disease (experimental group), classified in stages I–III of the Hoehn and Yahr Scale, were included. The diagnosis was based on the criteria of the Brain Bank for Neurological Diseases, National Hospital for Neurology and Neurosurgery, in London, which requires the presence of bradykinesia and at least one of the three cardinal signs of Parkinson's disease: tremor at rest, muscle rigidity, and postural instability. The control group was matched for age and gender in relation to the experimental group, and included 29 volunteers from the community. Inclusion criteria for this group were the absence of neurological diseases and body imbalance, no history of vestibular and/or auditory symptoms, and a vectoelectronystagmography vestibular examination within normal reference parameters. The exclusion criteria included patients who showed changes in the external and/or middle ear those with psychiatric disorders, history of ear; surgery, inability to understand and follow simple verbal commands, inability to remain in the upright position independently; or who had severe visual impairment not compensated with corrective lenses, orthopedic disorders resulting in limited movement, used prosthetic legs, or who have received body balance rehabilitation in the last six months. Patients with Parkinson's disease were assessed during the on period, between 40 min and 2 h after administration of levodopa, when they exhibited better motor performance. Static Tetrax™ posturography includes a specific program installed on a computerized platform composed of four independent and integrated platforms (A–B–C–D), placed on level ground, uncarpeted, with a handrail and a foam mat. Patients placed their toes and heels on the four platforms (A – left heel; B – left toes; C – right heel, D – right toes) with arms outstretched alongside the body, and were instructed to maintain an upright, stable, and immobile posture for 32 s for each of the eight sensory conditions: “face forward, eyes open, looking at a target on the wall opposite the platform on firm surface” (NO); “face forward, eyes closed on a firm surface” (NC); “eyes closed, 45° of head rotation to the right on a firm surface” (HR); “eyes closed, 45° of head rotation to the left on a firm surface” (HL); “eyes closed, head tilted 30° backward on a firm surface” (HB); “eyes closed, head tilted 30° forward on a firm surface” (HF), “face forward, eyes open, looking at a target on the wall opposite the platform on a unstable surface on a cushion” (PO); and “face forward, eyes closed on an unstable surface on a cushion” (PC). The posturography with Tetrax™ evaluated the following parameters: stability index, weight distribution index, left/right and toes/heel synchronization index, postural oscillation frequency (F1, F2–F4, F5–F6, and F7–F8), and fall index. The stability index, regardless of weight and height, indicates the overall stability and the ability to make postural changes. This index assesses the amount of oscillation on the four platforms of Tetrax™. The weight distribution index, expressed as a percentage, is measured by comparing the deviations from the weight distribution on each platform with respect to an expected average value of 25%. The synchronization index between the heel and toes of each foot (AB, CD), between the two heels and toes of both feet (AC, BD), and between the heel of one foot with the contralateral toes (AD, BC) measures the coordination between the lower limbs and the symmetry in the distribution of weight in each condition. The frequency of postural oscillation, measured by Fourier transformation, determines the intensity of postural oscillation in a variable spectrum between 0.01 and 3.0 Hz. Tetrax™ subdivides the spectrum of postural oscillation in four frequency ranges: low (F1), below 0.1 Hz; medium-low (F2–F4), between 0.1 and 0.5 Hz; medium-high (F5–F6), between 0.5 and 1.0 Hz; and high (F7–F8), above 1.0 Hz. The fall index, expressed as a percentage and ranging between 0 and 100, analyzes the results of Tetrax™ parameters in the eight conditions. A value between 0% and 36% is judged as mild risk; a value between 37% and 58%, as moderate risk; and between 59% and 100%, as high risk. The higher the score, the greater the risk of occurrence of a fall. All data were submitted to descriptive statistics for sample characterization. Levene's test was used to analyze the equivalence of variances with respect to age, and the chi-squared test was used for the analysis of homogeneity of genres between the control and experimental groups. The Shapiro–Wilk test was used to verify the normality of the variables. In the comparative analysis of experimental and control groups, the nonparametric Mann–Whitney test was used for the overall stability index, for left-right and toes/heel synchronization in the eight sensory conditions, and for the weight distribution index in the “NO”, “NC”, “PO”, “HR”, “HL”, and “HB” conditions. Student's t-test was used for independent samples, regarding age, fall index, postural oscillation frequencies (F1, F2–F4, F5–F6, and F7–F8) in all conditions, and weight distribution index in “PC” and “HF” conditions. Data were presented as mean ± standard deviation. The level of significance was set at p < 0.05. Predictive Analytics Software (PASW, version 18.0) was used for calculations.

Results

A total of 59 patients were evaluated: 30 in the experimental group, of whom 18 (60.0%) were male and 12 (40.0%) female, and 29 in the control group, of whom 11 (37.9%) were male and 18 (62.1%) female. The mean age (±SD) of the group with Parkinson's disease was 59.8 ± 10.3 years. The mean age (±SD) of the control group was 58.9 ± 9.8 years. The groups were homogeneous with respect to gender (p = 0.151) and age (p = 0.488). On average, the risk of occurrence of a fall was moderate (mean ± SD = 42.1 ± 25.5) in patients with Parkinson's disease and mild (mean ± SD = 22.7 ± 13.7) in the control group. The group with Parkinson's disease showed a higher risk of fall versus the control group, with a statistically significant difference (p = 0.001). Table 1 presents a comparative analysis of the stability index and of the weight distribution index of both groups on Tetrax™. There was no statistically significant difference between the groups regarding the stability index in the studied conditions. The weight distribution index was higher in patients with Parkinson's than in the control group in all conditions of Tetrax™, with a statistically significant difference in “NO”, “NC”, “PO”, and “PC” conditions.
Table 1

Analysis of the stability index and weight distribution index in the eight conditions of the Tetrax™ interactive balance system in 29 control subjects and 30 patients with Parkinson's disease.

ConditionStability index
Weight distribution index
ParkinsonControlp-ValueParkinsonControlp-Value
NO14.2 ± 4.713.3 ± 3.50.832a7.1 ± 3.44.9 ± 2.60.015a, b
NC20.8 ± 9.618.4 ± 6.10.628a6.5 ± 3.14.7 ± 2.40.042a, b
PO19.1 ± 5.918.2 ± 6.70.363a7.1 ± 2.95.0 ± 2.60.005a, b
PC27.9 ± 9.328.4 ± 10.70.891a7.3 ± 2.74.2 ± 2.2<0.001b, c
HR19.5 ± 7.617.9 ± 5.40.638a6.6 ± 3.55.4 ± 2.80.159a
HL21.1 ± 8.417.9 ± 6.50.141a7.1 ± 3.15.5 ± 2.60.060a
HB20.9 ± 9.319.7 ± 6.40.952a6.4 ± 2.95.2 ± 2.90.111a
HF19.6 ± 8.618.0 ± 4.50.879a6.5 ± 3.05.4 ± 2.50.163c

NO, eyes open on a firm surface; NC, eyes closed on a firm surface; PO, eyes open on an unstable surface; PC, eyes closed on an unstable surface; HR, eyes closed with head rotation to the right on a firm surface; HL, eyes closed with head rotation to the left on a firm surface; HB, eyes closed, head tilted backward 30° on a firm surface; HF, eyes closed, head tilted forward 30° on a firm surface.

Values = mean ± standard deviation.

Mann–Whitney test.

Statistically significant difference between the groups (p < 0.05).

Student's t- test.

Analysis of the stability index and weight distribution index in the eight conditions of the Tetrax™ interactive balance system in 29 control subjects and 30 patients with Parkinson's disease. NO, eyes open on a firm surface; NC, eyes closed on a firm surface; PO, eyes open on an unstable surface; PC, eyes closed on an unstable surface; HR, eyes closed with head rotation to the right on a firm surface; HL, eyes closed with head rotation to the left on a firm surface; HB, eyes closed, head tilted backward 30° on a firm surface; HF, eyes closed, head tilted forward 30° on a firm surface. Values = mean ± standard deviation. Mann–Whitney test. Statistically significant difference between the groups (p < 0.05). Student's t- test. Table 2 shows the comparative analysis of the postural oscillation frequency ranges (F1, F2–F4, F5–F6, and F7–F8) in the control and experimental groups in the eight sensory conditions of Tetrax™. The group with Parkinson's disease had higher values versus the control group in all frequency ranges and in all sensory conditions.
Table 2

Comparative analysis of Fourier frequency ranges in the eight conditions of the Tetrax™ interactive balance system in 29 control subjects and 30 patients with Parkinson's disease.

ConditionF1
F2–F4
ParkinsonControlp-ValueParkinsonControlp-Value
NO13.57 ± 7.6911.36 ± 5.870.2186.98 ± 1.906.35 ± 1.720.186
NC16.29 ± 7.1314.28 ± 7.130.2849.95 ± 2.868.75 ± 2.640.099
PO22.74 ± 22.7416.91 ± 7.820.0568.87 ± 3.577.25 ± 2.320.044a
PC24.42 ± 15.6821.81 ± 15.010.51613.66 ± 4.1211.34 ± 3.910.030a
HR15.55 ± 8.5513.65 ± 7.410.3658.90 ± 2.498.01 ± 2.640.190
HL15.51 ± 7.6614.77 ± 9.780.7499.20 ± 2.547.67 ± 1.960.012a
HB19.79 ± 10.1117.85 ± 9.530.4519.70 ± 2.938.47 ± 2.700.099
HF16.89 ± 8.1113.80 ± 6.760.1189.05 ± 2.367.87 ± 1.990.043a

NO, eyes open on a firm surface; NC, eyes closed on a firm surface; PO, eyes open on an unstable surface; PC, eyes closed on an unstable surface; HR, eyes closed with head rotation to the right on a firm surface; HL, eyes closed with head rotation to the left on a firm surface; HB, eyes closed, head tilted 30° backward on a firm surface; HF, eyes closed, head tilted forward 30° on firm surface.

F1, F2–F4, F5–F6, F7–F8, postural oscillation frequency ranges.

Values are shown as mean ± standard deviation.

Student's t-test.

Statistically significant difference between the groups (p < 0.05).

Comparative analysis of Fourier frequency ranges in the eight conditions of the Tetrax™ interactive balance system in 29 control subjects and 30 patients with Parkinson's disease. NO, eyes open on a firm surface; NC, eyes closed on a firm surface; PO, eyes open on an unstable surface; PC, eyes closed on an unstable surface; HR, eyes closed with head rotation to the right on a firm surface; HL, eyes closed with head rotation to the left on a firm surface; HB, eyes closed, head tilted 30° backward on a firm surface; HF, eyes closed, head tilted forward 30° on firm surface. F1, F2–F4, F5–F6, F7–F8, postural oscillation frequency ranges. Values are shown as mean ± standard deviation. Student's t-test. Statistically significant difference between the groups (p < 0.05). There was a statistically significant difference between the groups in the F2–F4 range in “PO”, “PC”, “HL”, and “HF” conditions. There was no statistically significant difference in “NO”, “NC”, “HR”, and “HB” conditions. Table 3 shows the comparative analysis of the right/left and toes/heel synchronization index of the control and experimental groups in the eight sensory conditions of Tetrax™.
Table 3

Comparative analysis of synchronization indexes in the eight conditions of the Tetrax™ interactive balance system in 29 control subjects and 30 patients with Parkinson's disease.

ConditionAB
CD
AC
ParkinsonControlParkinsonControlParkinsonControl
NO−629.4 ± 390.4−775.1 ± 163.4−661.2 ± 223.0a−783.9 ± 159.9278.6 ± 463.2a530.9 ± 276.1
NC−825.3 ± 171.4−811.3 ± 246.8−830.8 ± 191.2−854.1 ± 150.5683.1 ± 296.9643.5 ± 307.4
PO−591.7 ± 365.3−655.5 ± 267.7−636.6 ± 337.1−711.6 ± 287.0511.0 ± 398.4626.7 ± 335.4
PC−708.8 ± 243.1−815.2 ± 139.3−740.4 ± 248.7−850.5 ± 94.8608.9 ± 317.3a778.1 ± 128.7
HR−668.7 ± 365.4−766.8 ± 271.4−773.7 ± 162.3−810.4 ± 193.0554.6 ± 382.3578.7 ± 329.0
HL−701.3 ± 246.9a−827.8 ± 179.9−711.2 ± 317.0a−863.9 ± 105.4508.9 ± 363.7668.6 ± 224.5
HB−759.5 ± 253.7−817.4 ± 203.9−776.3 ± 327.5−857.8 ± 201.2669.2 ± 342.4662.8 ± 312.2
HF−709.9 ± 319.2−844.4 ± 163.0−813.3 ± 205.1−841.5 ± 196.7635.6 ± 286.0628.7 ± 278.7

AB, synchronization index between platforms regarding left toes and heel; CD, synchronization index between right toes and heel; AC, synchronization index between both heels; BD, synchronization index between both forefeet; AD, synchronization index between left and right toes; BC, synchronization index between left toes and right heel; NO, eyes open on a firm surface; NC, eyes closed on a firm surface; PO, eyes open on an unstable surface; PC, eyes closed on an unstable surface; HR, eyes closed with head rotation to the right on a firm surface; HL, eyes closed with head rotation to the left on a firm surface; HB, eyes closed, head tilted backward 30° on a firm surface; HF, eyes closed, head tilted forward 30° on a firm surface.

Values shown are mean ± standard deviation.

Mann–Whitney test.

Statistically significant difference between the group with Parkinson's disease and the control group (p < 0.05).

Comparative analysis of synchronization indexes in the eight conditions of the Tetrax™ interactive balance system in 29 control subjects and 30 patients with Parkinson's disease. AB, synchronization index between platforms regarding left toes and heel; CD, synchronization index between right toes and heel; AC, synchronization index between both heels; BD, synchronization index between both forefeet; AD, synchronization index between left and right toes; BC, synchronization index between left toes and right heel; NO, eyes open on a firm surface; NC, eyes closed on a firm surface; PO, eyes open on an unstable surface; PC, eyes closed on an unstable surface; HR, eyes closed with head rotation to the right on a firm surface; HL, eyes closed with head rotation to the left on a firm surface; HB, eyes closed, head tilted backward 30° on a firm surface; HF, eyes closed, head tilted forward 30° on a firm surface. Values shown are mean ± standard deviation. Mann–Whitney test. Statistically significant difference between the group with Parkinson's disease and the control group (p < 0.05). There was a statistically significant difference between the groups, with lower values in the group of Parkinson's patients in synchronizations “CD” (p = 0.018) and “AC” (p = 0.033) in “NO” condition; in synchronization “BC” (p = 0.017) in “PO” condition; in synchronizations “BC” (p = 0.035) and “AC” (p = 0.049) in “PC” condition; in synchronizations “AB” (p = 0.041) and “CD” (p = 0.022) in “HL” condition. The difference between the synchronization indexes AB “exhibited” borderline significance (p = 0.05) in “PC”. There was no significant difference between the groups in synchronizations AB, CD, AC, BD, AD, and BC (p > 0.05) in “NC”, “HR”, “HB” and “HF” conditions.

Discussion

The findings of the static Tetrax™ posturography in the group of patients with Parkinson's disease were compared to those obtained in the control group. There are limitations in the quantitative comparison of results with those of other posturographies, since Tetrax™ employs different parameters and methods of evaluation. Tetrax™ provides the fall index through a mathematical algorithm which is based on the patient's performance in the various evaluated parameters. In the present study, the risk of occurrence of a fall was, on average, mild in the control group and moderate in the Parkinson's disease group; it was significantly higher in patients with Parkinson's disease, in agreement with the findings of a survey also conducted with Tetrax™ in mild or moderate Parkinson's disease, in accordance with the Hoehn-Yahr scale (modified), but in disagreement with another study on patients in the early stages of Parkinson's disease, which identified no significant difference versus control group. Postural instability is a major problem in Parkinson's disease, and the occurrence of falls is one of its most serious complications. The percentage of patients suffering falls varies between 38% and 68%. With disease progression, the frequency of falls increases. The identification of the fall risk can lessen the risk for the occurrence of this event in the future, through early intervention. Most studies investigating the fall risk use data from questionnaires or in patient reports to predict future falls. However, patients often do not accurately remember the details of previous falls, of the interval between the events, and, importantly, whether they have occurred over a long period of time. The values of the weight distribution index were significantly higher in patients with Parkinson's disease, compared to that in the control group, in four of the eight evaluated sensory conditions: “NO”, “NC”, “PO”, and “PC”. Similar to the present findings, another study employing Tetrax™ showed a significant difference in the “NO and “NC” sensory conditions; but unlike the present study results, significantly higher values were observed in “HR”, “HB” (head backwards), and HF (“head forward”) conditions. The higher the weight distribution index, the greater the difficulty in maintaining posture. The stability index of the group with Parkinson's disease was similar to that of the control group in all the evaluated sensory conditions. However, compared with the control group, in Parkinson's disease it was reported that the stability index in Tetrax™ was higher only in “NC” condition, with no significant difference in other conditions. With other types of static posturography, some authors have demonstrated in Parkinsonian patients a significantly greater oscillation area in “eyes open and eyes closed on a firm surface” conditions,32, 33, 34 while others have observed no significant difference.18, 35 The values of left and right toes/heels synchronization index of the control group and of the group with Parkinson's disease were symmetrical in the eight sensory conditions. However, the group with Parkinson's disease had significantly lower values in synchronizations “CD” and “AC” in “NO” condition; “BC” in “PO” condition; “BC” and “AC” in “PC condition”; and “AB” and “CD” in “HL” condition. Significantly lower values were reported only in AC synchronization, in HB condition. The symmetry of the values of synchronizations could be due to adequate compensatory mechanisms and to the simultaneous activation of the parallel plates. Regarding the postural oscillation frequency ranges (F1, F2–F4, F5–F6, and F7–F8), the group with Parkinson's disease showed significantly higher values versus the control group only in the range F2–F4 in “PO”, “PC”, “HL” and “HF” conditions, suggesting peripheral vestibular dysfunction. Both groups showed dominance of oscillation at low frequencies, indicating visual preference to maintain postural control. Significant differences between the group with Parkinson's disease and the control group were also found with Tetrax™ in F2–F4 frequency ranges in “NC”, “HL”, “HR”, “HF”, and “HB” conditions; in F5–F6 ranges in NC and HL conditions; and in the F7–F8 ranges in NC, HL, and HR conditions. In patients in the early stages of Parkinson's disease, Tetrax™ identified greater involvement of the central vestibular system, characterized by greater oscillation in the F7–F8 frequency range. The difference found between the groups in F2–F4 range may have been an attempt to compensate for a proprioceptive impairment. The decrease in proprioceptive information on unstable surface conditions, a restriction of movement and a rigidity to change in the head position may have hampered the maintenance of posture. The deterioration of proprioceptive information can cause postural instability.36, 37, 38 In this research, it was observed that the Tetrax™ posturography provides relevant information regarding the stability index, weight distribution index, right/left and toes/heels synchronization index, frequency ranges of postural oscillation (F1, F2–F4, F5–F6, F7–F8), and fall index in the assessment of postural control in Parkinson's disease. The characterization of a body balance disorder in each patient with this condition may have diagnostic, therapeutic, and even preventive implications. Further research should be conducted in this area in order to better understand the relationship among postural control and the different stages of Parkinson's disease, as well as the possible role of prophylactic or therapeutic procedures for body balance rehabilitation in solving or mitigating the imbalance and in eliminating or reducing the risk of falls in these patients.

Conclusion

Impaired postural control in patients with Parkinson's disease in Tetrax™ posturography is characterized by changes in distribution of weight in the synchronization of right/left and toes/heels postural oscillation, in the postural oscillation frequency ranges, and in the fall index.

Funding

This study was supported by – CAPES.

Conflicts of interest

The authors declare no conflicts of interest.
  23 in total

1.  Postural control in Parkinson patients: a proprioceptive problem?

Authors:  Mark G Carpenter; Bastiaan R Bloem
Journal:  Exp Neurol       Date:  2010-11-16       Impact factor: 5.330

2.  Posturography reflects clinical imbalance in Parkinson's disease.

Authors:  Georg Ebersbach; Maren Gunkel
Journal:  Mov Disord       Date:  2010-12-13       Impact factor: 10.338

3.  Falls incidence underestimates the risk of fall-related injuries in older age groups: a comparison with the FARE (Falls risk by Exposure).

Authors:  Astrid Etman; Gert Jan Wijlhuizen; Marieke J G van Heuvelen; Astrid Chorus; Marijke Hopman-Rock
Journal:  Age Ageing       Date:  2012-03       Impact factor: 10.668

4.  Parkinsonism: onset, progression and mortality.

Authors:  M M Hoehn; M D Yahr
Journal:  Neurology       Date:  1967-05       Impact factor: 9.910

5.  Assessment of postural control in patients with Parkinson's disease: sway ratio analysis.

Authors:  Janusz W Błaszczyk; Renata Orawiec
Journal:  Hum Mov Sci       Date:  2010-08-30       Impact factor: 2.161

6.  [Daily living activities evaluation in Parkinson's disease patients underwent to stereotactic surgery].

Authors:  Roberta Arb Saba Rodrigues Pinto; Vanderci Borges; Patrícia Maria C Aguiar; Fernando A P Ferraz; Marcelo Ken-Iti Hisatugo; Henrique Ballalai Ferraz
Journal:  Arq Neuropsiquiatr       Date:  2002-06       Impact factor: 1.420

7.  A meta-analysis of six prospective studies of falling in Parkinson's disease.

Authors:  Ruth M Pickering; Yvette A M Grimbergen; Una Rigney; Ann Ashburn; Gordon Mazibrada; Brian Wood; Peggy Gray; Graham Kerr; Bastiaan R Bloem
Journal:  Mov Disord       Date:  2007-10-15       Impact factor: 10.338

8.  Discordance between measured postural instability and absence of clinical symptoms in Parkinson's disease patients in the early stages of the disease.

Authors:  Nathalie Chastan; Bertrand Debono; David Maltête; Jacques Weber
Journal:  Mov Disord       Date:  2008-02-15       Impact factor: 10.338

9.  Balance confidence and functional mobility are independently associated with falls in people with Parkinson's disease.

Authors:  Margaret K Y Mak; Marco Y C Pang
Journal:  J Neurol       Date:  2009-02-25       Impact factor: 4.849

10.  The effect of pramipexole therapy on balance disorder and fall risk in Parkinson's disease at early stage: clinical and posturographic assessment.

Authors:  Sibel Güler; Levent Sinan Bir; Beyza Akdag; Fusun Ardıc
Journal:  ISRN Neurol       Date:  2012-08-05
View more
  4 in total

1.  Posturographic examination of body balance in patients with Chiari type I malformation and correlation with the presence of syringomyelia and degree of cerebellar ectopia.

Authors:  Deniz Palamar; Hüseyin Güler; Murat Hancı; Hamza Sucuoğlu; Galip Zihni Sanus; Şansın Tüzün
Journal:  Turk J Phys Med Rehabil       Date:  2018-03-11

2.  A posturographic procedure assessing balance disorders in Parkinson's disease: a systematic review.

Authors:  Anna Kamieniarz; Justyna Michalska; Anna Brachman; Michał Pawłowski; Kajetan J Słomka; Grzegorz Juras
Journal:  Clin Interv Aging       Date:  2018-11-12       Impact factor: 4.458

Review 3.  The Role of Movement Analysis in Diagnosing and Monitoring Neurodegenerative Conditions: Insights from Gait and Postural Control.

Authors:  Christopher Buckley; Lisa Alcock; Ríona McArdle; Rana Zia Ur Rehman; Silvia Del Din; Claudia Mazzà; Alison J Yarnall; Lynn Rochester
Journal:  Brain Sci       Date:  2019-02-06

4.  Relationship between Muscular Activity and Postural Control Changes after Proprioceptive Focal Stimulation (Equistasi®) in Middle-Moderate Parkinson's Disease Patients: An Explorative Study.

Authors:  Fabiola Spolaor; Marco Romanato; Guiotto Annamaria; Antonella Peppe; Leila Bakdounes; Duc-Khanh To; Daniele Volpe; Zimi Sawacha
Journal:  Sensors (Basel)       Date:  2021-01-14       Impact factor: 3.576

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.